Parkwood »

Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Parkwood

Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Parkwood from 13F filings

Historical chart of Parkwood investment in Karyopharm Therapeutics Inc note 3.000%10/1

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Parkwood consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Parkwood

Quarter filed Position value Share count Share price at filing
2023-03-31 $771k 1.0M 0.77

More positions owned by Parkwood

Vanguard Total Stock Mkt Etf Etp (VTI)
Ishares Russell 2000 Etf Etp Put Option (IWM)
Spdr S&p 500 Etf Trust Etp Put Option (SPY)
Spdr Bloomberg 1-3 Month T-b Etp (BIL)
Kraneshares Csi China Intern Etp Call Option (KWEB)
Ishares 20 Year Treasury Bo Etp Call Option (TLT)
Roblox Corp -class A Common Stock (RBLX)
Vanguard Ftse Emerging Marke Etp (VWO)
Ark Innovation Etf Etp (ARKK)
Totalenergies Se - Adr (TTE)
Elevance Health Common Stock (ELV)
Canadian Natural Resources Common Stock (CNQ)
Vanguard Tot World Stk Etf Etp (VT)
Apollo Global Management Common Stock (APO)
Novo-nordisk A/s-spons Adr (NVO)

View all positions for Parkwood

Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1

Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Context Capital Management
Birch Grove Capital
Capstone Investment Advisors
Lazard Asset Management
DeepCurrents Investment Group
BLB^B Advisors
Jpmorgan Chase & Co

View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1